How do you measure ovulation with Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), and progesterone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Measuring Ovulation with FSH, LH, and Progesterone

To accurately measure ovulation, progesterone levels during the mid-luteal phase (approximately 7 days after suspected ovulation) provide the most reliable hormonal indicator, with levels ≥5 ng/ml confirming ovulation has occurred.

Hormonal Patterns During Normal Ovulatory Cycle

Follicular Phase (Early Cycle) Assessment

  • Baseline FSH and LH measurements should be taken between days 3-6 of the menstrual cycle, with accurate assessment calculated as the average of three estimations taken 20 minutes apart 1, 2
  • During early follicular phase, FSH levels are typically higher than LH levels 3
  • Normal LH/FSH ratio should be less than 2; a ratio >2 suggests PCOS and likely anovulation 1, 2

Mid-Cycle (Ovulation) Assessment

  • LH surge occurs approximately 24-36 hours before ovulation 2
  • Both LH and FSH peak at mid-cycle, with LH showing a more dramatic increase 3, 4
  • Urinary LH testing can predict ovulation within 48 hours with 92% positive predictive value 5

Luteal Phase Assessment

  • Progesterone measurement during mid-luteal phase (approximately 7 days after suspected ovulation or day 21 of a 28-day cycle) is the most reliable hormonal indicator of ovulation 6, 2
  • A serum progesterone level ≥5 ng/ml (≥16 nmol/L) on day 21 confirms ovulation has occurred 6
  • Progesterone levels during luteal phase should be 10-15 times higher than during follicular phase (typically 12.4 ± 2.3 ng/ml in luteal phase vs. 0.65 ± 0.12 ng/ml in follicular phase) 3
  • Low mid-luteal phase progesterone levels (<6 nmol/L) indicate anovulation 1, 2

Practical Approach to Measuring Ovulation

Timing of Hormone Measurements

  • For FSH/LH baseline: Measure on days 3-6 of menstrual cycle 1, 2
  • For progesterone: Measure on day 21 of a 28-day cycle (or 7 days before expected menses in irregular cycles) 6
  • For women with irregular cycles, testing should be performed approximately 7 days before expected menses to capture mid-luteal phase 6

Interpreting Results

  • Normal ovulatory pattern shows:
    • Mid-cycle LH peak 3
    • Progesterone levels at luteal phase 10-15 times greater than follicular phase 3
    • Progesterone peak at mid-luteal phase 3
    • Luteal phase duration of 12-15 days 3

Abnormal Patterns Suggesting Anovulation

  • LH:FSH ratio >2 suggests PCOS 1, 2
  • FSH >35 IU/L and LH >11 IU/L suggest ovarian failure 1, 2
  • LH <7 IU/mL may indicate hypothalamic dysfunction 1, 2
  • Progesterone <5 ng/ml during mid-luteal phase suggests anovulation, mistimed sample, or luteal phase defect 6

Common Pitfalls and Considerations

  • Timing of sample collection is critical - measurements must be taken at specific points in the cycle 2
  • The "day 21" progesterone timing is based on a 28-day cycle; adjustment needed for women with irregular cycles 6
  • Medications, particularly hormonal contraceptives, can suppress normal hormone patterns and affect results 6, 2
  • Some conditions like PCOS can show elevated LH levels throughout the cycle, masking the typical surge pattern 2
  • A single hormone measurement may be insufficient; serial measurements provide more reliable information 7

Alternative Assessment Methods

  • Urinary LH testing (surge precedes ovulation by 24-36 hours) can be used as a home-based alternative method 6, 5
  • Transvaginal ultrasound to monitor follicular development and collapse is the most direct method to confirm ovulation 7, 5
  • Combined approaches using both hormone measurements and ultrasound provide the most comprehensive assessment 7, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.